October 8, 2025
TransCelerate Advances Industrywide Shift To Digital Protocols
Explore
Press Releases
September 15, 2025
TransCelerate and Tufts CSDD Uncover Opportunities to Rethink Data Collection and Optimize Protocol Design
Explore
August 19, 2025
TransCelerate and FDA Collaborate to Advance Use of Pragmatic Elements in Clinical Trials
Explore
June 11, 2025
TransCelerate BioPharma to Highlight Collaboration, Innovation, and Patient-Centric Research at DIA 2025
Explore
March 3, 2025
TransCelerate BioPharma Publishes Resources to Accelerate Industry Adoption of Newly-Released ICH E6(R3) Guidelines
Explore
February 18, 2025
TransCelerate BioPharma Releases 2024 Annual Report, Highlights Strategic Vision and Announces Board Leadership Transition
Explore
January 31, 2025
Driving Innovation and Collaboration: TransCelerate BioPharma Champions the Future of R&D
Explore
January 24, 2024
TransCelerate BioPharma Organized for Growth and Bringing New Innovation and Collaboration to the Biopharmaceutical R&D Community
Explore
October 13, 2022
TransCelerate BioPharma Appoints Janice Chang as New CEO
TransCelerate BioPharma Inc., today announced that Janice Chang, currently its Chief Operating Officer, has been appointed as TransCelerate’s new Chief Executive Officer. Janice will assume the role on January 1, 2023. Read more in the press release.
Explore
September 9, 2021
TransCelerate BioPharma Commences Collaborative Development of a Novel Digital Data Flow Solution for Study Start-Up
TransCelerate BioPharma Inc. (TransCelerate) announced today that it has commenced development on a reference implementation of a study definitions repository. The study definitions repository is a novel central component aimed at facilitating the exchange of structured study definitions across clinical systems using technical and data standards. For the full press release, please click here.
Explore